Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
Key Takeaway: In July, consumer expectations for stocks dropped to their lowest level since March 2009. Excessive optimism is clearly not an issue for stocks right here. But bulls need...
With the rise in $VIX (the "fear gauge") over the past several trading days continuing to persist, we've been on the hunt for options premium selling opportunities. Higher volatility environments lend themselves to better opportunities for premium...
We had a resting GTC order filled at our profit target and we pre-emptively closed another position to book a profit in the Paid-to-Play portfolio today:
We retired our "Five Bull Market Barometers" in 2020 to make room for a new weekly post that's focused on the three most important charts for the week ahead.
